A Phase 1/2 interventional study of Hyaluronic acid and Syringes in Temporomandibular Joint Disorders and Arthrocentesis, sponsored by Basel khaled mohamed. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-11-19.
Sponsored by Basel khaled mohamed · Phase 1/2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 63 studies in Temporomandibular Joint Disorders with a site in Egypt — 10 open to participants now, 14 under way, none of them phase 3. Temporomandibular Joint Disorders · Egypt.
Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, this one is the 23rd largest by planned enrollment of the 49 interventional ones that give a count, is one of 12 that started in 2023, is the only one in phase 1/2, reaches primary completion later than 6 of the 13 other live ones, and was the 29th registered.
593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.
Browse Temporomandibular Joint Disorders studies →10 of the 63 studies in Temporomandibular Joint Disorders with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18–65
Future University in Egypt · Sites in Egypt
Ages 18–60
Horus University · Sites in Egypt
Ages 18–45 · Healthy volunteers
Nourhan M.Aly · Sites in Egypt
Ages 20–40
Cairo University · Sites in Egypt
Ages 18–40
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
63 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 4 2
First in 2016; this study’s year is marked. 12 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 45 across 417 interventional studies indexed under Temporomandibular Joint Disorders.
Median enrollment 30 across the 49 interventional studies, 88 across the 14 observational. Of the 42 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 63 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Basel khaled mohamed as lead sponsor.
Basel khaled mohamed has 1 study filed under Temporomandibular Joint Disorders — fewer than ten, so there is no comparison to draw.
4 of the studies in Temporomandibular Joint Disorders with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07878247Future University in EgyptClinical and Electromyographic Assessment of Occlusal Splint Therapy | 2026-12-01 |
| NCT07626164Alexandria UniversityThree Photobiomodulation Wavelengths (635, 940, and 1064 nm) on Chronic Myogenic Temporomandibular Disorder | 2026-12-30 |
| NCT07614932Cairo UniversityArthroscopic Lysis and Lavage With and Without Intra-articular Injection of Hyaluronic Acid in Patients With DDwoR in TMJ | 2027-01 |
| NCT07486609Cairo UniversityDiagnostic Study Accuracy of Jaw Motion Analyzer(JMA) Versus Research Diagnostic Criteria(RDC/TMD) and Magnetic Resonance Imaging(MRI) for Temporomandibular Disorders Among Patients With Chronic Orofacial Pain. | 2027-01-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study will be carried out in Patients in two Groups aged between 17 to 70 years , of both sexes, who had painful symptoms, with or without presence of joint noise, and had unilateral or bilateral internal derangement of the TMJ proven by clinical examination, with no improvement after conservative treatment.
The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder.
, 1- significantly improving the pain on scale 1-10 , and 2-significant improvements in mouth opening range in mm by the distance between the edges of the frontal incisors with a ruler or caliper and joint noise.
3-The presence of absence of clicking and cracking in jaw .
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients injected e high molucular weight hyalurinic acid .
Drug: Hyaluronic acid · Device: Syringes
patients injected with low molucular weight hyalurinic acid .
Drug: Hyaluronic acid · Device: Syringes
Comparative study between Hyalgan and Hyorth injectable products in TMJ Disorders by arthrocentesis of 2 syringes device
Also known as: Arthrocentesis
Whilst you are asleep, two small needles will be inserted into the TMJ / Jaw Joint. One of these needles allows sterile saline to be pumped into the joint under pressure whilst the other needle allows the saline to drain out of the joint then injection of the HA injectiable products .
Also known as: Arthrocentesis
EFFICACY between injection of high versus low molecular weight hyaluronic acid in TMJ arthrocentesis
The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder. , 1- significantly improving the pain on scale 1-10 , and
Time frame: 36 months
comparative between injection of high versus low molecular weight hyaluronic acid in TMJ arthrocentesis
The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder. 2-significant improvements in mouth opening range in mm by the distance between the edges of the frontal incisors with a ruler or caliper and joint noise.
Time frame: 36 months
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Feb 2026, 27 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Hyaluronic Acid
Temporomandibular Joint Disorders →